This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Meta received data on pregnancy, period cycles, expert for Flo users tells US jury

By Xu Yuan and Mike Swift ( July 24, 2025, 00:40 GMT | Insight) -- Personal information provided by users to Flo, a period and ovulation tracking app, concerning their reproductive health was sent to Meta Platforms through its software development tools, a privacy expert for the users told a federal jury.  Serge Egelman, a research scientist at the University of California, Berkeley, today walked the eight-person jury through the computer code that he got by reverse engineering the Flo app to show the alleged data sharing between Flo and Meta, which are being sued by the users.Personal information provided by users to Flo, a period and ovulation tracking app, concerning their reproductive health was sent to Meta Platforms through its software development tools, a privacy expert for the users — who are suing Flo and Meta — told a federal jury....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections